Precigen (PGEN) Raw materials — Quarterly & Annual

Screener

Raw materials at other companies

Regeneron PharmaceuticalsREGN

$610.9M-18.8%

Gilead SciencesGILD

$1.42B+11.3%

ALN

Alnylam PharmaceuticalsALNY

$13.91M-39.2%

AmgenAMGN

$1.08B+22.3%

Other financials

Income statement

Revenue$23.3M+1,634%

Operating income-$6.0M+73.5%

Net income-$7.9M+85.4%

EPS (diluted)-$0.02+88.9%

Balance sheet

Cash & equivalents$7.5M+23.5%

Total debt$98.3M+1,714%

Total equity$20.2M+244%

Total assets$138.6M+7.6%

Cash flow

Operating cash flow-$43.8M-168%

CapEx$258.0K-58.5%

Free cash flow-$44.1M-160%

Valuation

Market cap$2.59B+404%

Enterprise value$2.68B+431%

P/S97.5×—

Profitability

Gross margin83.6%—

Operating margin-2,890.9%—

Net margin-3,656%—

FCF margin-1,756.5%—

Returns & leverage

Return on equity-843.6%-1,103pp

Debt / equity4.9×—

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterials.

The source filing: Precigen’s 10-Q, filed May 13, 2026.

Filed: May 13, 2026, 4:20 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001356090-26-000017

Line item	March 31,2026	December 31,2025
Raw Material	$333	$144
Work in process	13,085	9,265
Finished Goods	1,307	172
Total inventory	$14,725	$9,581

Item 1. Condensed Consolidated Financial Statements

FAQ

What is Precigen's raw materials?: Precigen (PGEN) reported raw materials of $333K in Q1 2026.
What does raw materials mean?: Unprocessed materials and components purchased for use in manufacturing, valued at cost.

Ask your AI about Precigen's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk